Found: 5
Select item for more details and to access through your institution.
NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients.
- Published in:
- Journal of Neuro-Oncology, 2018, v. 137, n. 1, p. 39, doi. 10.1007/s11060-017-2558-x
- By:
- Publication type:
- Article
CORRIGENDUM: Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer.
- Published in:
- Nature Medicine, 2004, v. 10, n. 6, p. 649, doi. 10.1038/nm0604-649c
- By:
- Publication type:
- Article
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer.
- Published in:
- Nature Medicine, 2004, v. 10, n. 2, p. 145, doi. 10.1038/nm988
- By:
- Publication type:
- Article
Analysis of MRE11 and Mortality Among Adults With Muscle-Invasive Bladder Cancer Managed With Trimodality Therapy.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 11, p. e2242378, doi. 10.1001/jamanetworkopen.2022.42378
- By:
- Publication type:
- Article
CHAIRPERSON'S COLUMN.
- Published in:
- JAMA: Journal of the American Medical Association, 1990, v. 263, n. 9, p. 1288
- By:
- Publication type:
- Article